A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

Trial Profile

A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 10 Oct 2012

At a glance

  • Drugs Arundic acid (Primary)
  • Indications Stroke
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 10 Oct 2012 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
    • 12 Jun 2012 Planned number of patients (1320) added as reported by ClinicalTrials.gov..
    • 12 Jun 2012 Additional lead trial investigator (Bryan Due) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top